Contract drug manufacturer Thermo Fisher Scientific said on Tuesday it will buy Solventum's purification and filtration ...

Waltham-based Thermo is buying the business from Solventum, a Minnesota-based company that spun off from manufacturing ...

Shares of Thermo Fisher Scientific Inc. TMO rose 1.10% to $528.96 Friday, on what proved to be an all-around positive trading ...

We recently published a list of 10 Best Affordable Dividend Stocks to Buy According to Hedge Funds. In this article, we are ...

The addition of Solventum’s business provides a strategic fit with Thermo Fisher and will create value for customers, according to Marc N. Casper, chairman, president, and CEO of Thermo Fisher.

GlobalData analyst Dr Andrew S Thompson expects the deal to prompt a "shuffle" in Thermo Fisher’s life sciences unit.

Wall Street applauded the deal, sending shares of Solventum, the 3M spinoff, up 10% on Tuesday.

Rare Disease Day, an annual gathering hosted by the FDA and National Institutes of Health, was postponed. Medicare spending on 10 diabetes drugs, including popular GLP-1s, more than quadrupled over a ...

Shares of Thermo Fisher Scientific Inc. TMO shed 1.89% to $523.23 Thursday, on what proved to be an all-around rough trading ...

Thermo Fisher Scientific confirmed that it agreed to purchase Solventum's purification and fitration unit for $4.1 billion in ...

On the heels of a move to reduce its viral vector manufacturing workforce, Thermo Fisher is beefing up its biologics ...

Shares of Solventum jumped Tuesday and led S&P 500 gainers intraday after medical device maker Thermo Fisher Scientific said ...